JD

Joris De Maeyer

Executive in Biotech & VC Industry

Mechelen, Flemish Region

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Chief Operations Officer - COO

    2024

  • Founder

    2023

    Founder of a NewCo focused on muscle health within the cardiometabolic space, addressing conditions such as sarcopenic obesity.

  • Executive in Residence

    2023

  • Investment Director

    2020 - 2023

  • Venture Coach

    2016 - 2020

  • Board Observer

    2021

  • Managing Director - Life Science Consulting

    2013

2014 - 2022

  • Chief Executive Officer

    2021 - 2022

    Through various roles with increasing responsibilities, established and led the R&D organization, advancing a program from the development of a unique phenotypic screening platform to successful candidate selection, while contributing to securing over €20M in funding.

  • Acting Chief Executive Officer

    2021 - 2021

  • Chief Scientific Officer

    2019 - 2021

  • Director R&D

    2014 - 2019

2011 - 2013

  • Director Discovery

    2011 - 2013

    Led a team within the exploratory projects group, driving innovative strategies and contributing to early-stage program development. Led efforts to advance a program to clinical candidate selection, driving key decisions and collaborating across disciplines.

2007 - 2010

  • Manager Drug Discovery & Development

    2007 - 2010

    Collaborated with cross-functional development teams, contributing to both discovery, early- and late-stage development through to successful registration.

2001 - 2006

  • Scientist Drug Discovery

    2002 - 2006

  • Senior Associate Preclinical Development (GLP DMPK TOX QA)

    2001 - 2002

  • Auditor Surface Water Monitoring Network

    2001 - 2001

    Temporary assignment.